These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35821454)
1. The P2X1 receptor as a therapeutic target. Bennetts FM; Mobbs JI; Ventura S; Thal DM Purinergic Signal; 2022 Dec; 18(4):421-433. PubMed ID: 35821454 [TBL] [Abstract][Full Text] [Related]
2. Smooth muscle does not have a common P2x receptor phenotype: expression, ontogeny and function of P2x1 receptors in mouse ileum, bladder and reproductive systems. Vial C; Evans RJ Auton Neurosci; 2001 Sep; 92(1-2):56-64. PubMed ID: 11570704 [TBL] [Abstract][Full Text] [Related]
3. P2X1 receptors localized in lipid rafts mediate ATP motor responses in the human vas deferens longitudinal muscles. Donoso MV; Norambuena A; Navarrete C; Poblete I; Velasco A; Huidobro-Toro JP Biol Reprod; 2014 Feb; 90(2):23. PubMed ID: 24352557 [TBL] [Abstract][Full Text] [Related]
4. Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function. Kauffenstein G; Pelletier J; Lavoie EG; Kukulski F; Martín-Satué M; Dufresne SS; Frenette J; Ribas Fürstenau C; Sereda MJ; Toutain B; Henrion D; Sullivan R; Vial C; Sévigny J J Biol Chem; 2014 Oct; 289(41):28629-39. PubMed ID: 25160621 [TBL] [Abstract][Full Text] [Related]
5. Spatial distribution and developmental appearance of postjunctional P2X1 receptors on smooth muscle cells of the mouse vas deferens. Liang SX; Motin L; Moussa CE; Lavidis NA; Phillips WD Synapse; 2001 Oct; 42(1):1-11. PubMed ID: 11668586 [TBL] [Abstract][Full Text] [Related]
6. The purinergic component of human vas deferens contraction. Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-phenyl-5,6,7,8-tetrahydroquinoxaline derivatives and screening for P2X1-purinoceptor antagonist activity in isolated preparations of rat vas deferens, for translation into a male contraceptive†. Mathiew M; Dennis BM; Bennetts F; Su NNE; Nguyen N; Botteon A; Baell JB; Ventura S Biol Reprod; 2020 Aug; 103(2):323-332. PubMed ID: 32648904 [TBL] [Abstract][Full Text] [Related]
8. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Mulryan K; Gitterman DP; Lewis CJ; Vial C; Leckie BJ; Cobb AL; Brown JE; Conley EC; Buell G; Pritchard CA; Evans RJ Nature; 2000 Jan; 403(6765):86-9. PubMed ID: 10638758 [TBL] [Abstract][Full Text] [Related]
9. Enhanced purinergic contractile responses and P2X1 receptor expression in detrusor muscle during cycles of hypoxia-glucopenia and reoxygenation. Elliott RA; Tonnu A; Ghaffar N; Taylor AH; Tincello DG; Norman RI Exp Physiol; 2013 Dec; 98(12):1683-95. PubMed ID: 23975903 [TBL] [Abstract][Full Text] [Related]
10. The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Clifford EE; Parker K; Humphreys BD; Kertesy SB; Dubyak GR Blood; 1998 May; 91(9):3172-81. PubMed ID: 9558372 [TBL] [Abstract][Full Text] [Related]
11. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens. Bültmann R; Trendelenburg M; Tuluc F; Wittenburg H; Starke K Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):339-44. PubMed ID: 10344533 [TBL] [Abstract][Full Text] [Related]
12. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Vulchanova L; Arvidsson U; Riedl M; Wang J; Buell G; Surprenant A; North RA; Elde R Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8063-7. PubMed ID: 8755603 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Bailey SJ; Hourani SM Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645 [TBL] [Abstract][Full Text] [Related]
14. A fluorescent approach for identifying P2X1 ligands. Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951 [TBL] [Abstract][Full Text] [Related]
15. P2X1: a unique platelet receptor with a key role in thromboinflammation. Oury C; Wéra O Platelets; 2021 Oct; 32(7):902-908. PubMed ID: 33760688 [TBL] [Abstract][Full Text] [Related]
16. Calcium Signalling through Ligand-Gated Ion Channels such as P2X1 Receptors in the Platelet and other Non-Excitable Cells. Mahaut-Smith MP; Taylor KA; Evans RJ Adv Exp Med Biol; 2016; 898():305-29. PubMed ID: 27161234 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors. Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447 [TBL] [Abstract][Full Text] [Related]
18. Activation of Prejunctional P2x2/3 Heterotrimers by ATP Enhances the Cholinergic Tone in Obstructed Human Urinary Bladders. Silva-Ramos M; Silva I; Faria M; Ferreirinha F; Correia-de-Sá P J Pharmacol Exp Ther; 2020 Jan; 372(1):63-72. PubMed ID: 31636173 [TBL] [Abstract][Full Text] [Related]
19. The residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens. White CW; Short JL; Haynes JM; Evans RJ; Ventura S J Pharmacol Exp Ther; 2010 Nov; 335(2):489-96. PubMed ID: 20724483 [TBL] [Abstract][Full Text] [Related]
20. Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists. Tian M; Abdelrahman A; Baqi Y; Fuentes E; Azazna D; Spanier C; Densborn S; Hinz S; Schmid R; Müller CE J Med Chem; 2020 Jun; 63(11):6164-6178. PubMed ID: 32345019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]